RxSight
(NASDAQ) RXST
RxSight Financials at a Glance
Market Cap
$212.36M
Revenue (TTM)
$127.48M
Net Income (TTM)
-$46.64M
EPS (TTM)
-$1.14
P/E Ratio
-4.52
Dividend
$0.00
Beta (Volatility)
0.00 (Low)
Dividend
$0.00
Beta (Volatility)
0.00 (Low)
Price
$5.35
Volume
114,593
Open
$5.13
Price
$5.35
Volume
114,593
Open
$5.13
Previous Close
$5.35
Daily Range
$4.95 - $5.50
52-Week Range
$4.48 - $13.65
Estimated Earnings Date
Aug 6, 2026
Dividend
$0.00
Beta (Volatility)
0.00 (Low)
Price
$5.35
Volume
114,593
Open
$5.13
Previous Close
$5.35
Daily Range
$4.95 - $5.50
52-Week Range
$4.48 - $13.65
Estimated Earnings Date
Aug 6, 2026
RXST News
RXST: Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout RxSight
Industry
Healthcare Equipment and Supplies
Sector
Health CareEmployees
461
CEO
Ronald M. Kurtz, MD
Website
rxsight.comHeadquarters
Aliso Viejo, CA 92656, US
RXST Financials
Key Financial Metrics (TTM)
Gross Margin
77.02%
Operating Margin
-43.42%
Net Income Margin
-36.58%
Return on Equity
-17.01%
Return on Capital
-16.81%
Return on Assets
-15.34%
Earnings Yield
-22.12%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$212.36M
Shares Outstanding
41.40M
Volume
114.59K
Avg. Volume
815.63K
Financials (TTM)
Gross Profit
$98.18M
Operating Income
-$55.35M
EBITDA
-$43.24M
Operating Cash Flow
-$17.57M
Capital Expenditure
-$4.01M
Free Cash Flow
-$21.58M
Cash & ST Invst.
$217.88M
Total Debt
$10.83M
RxSight Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$30.89M
-18.5%
Gross Profit
$23.50M
-17.1%
Gross Margin
76.06%
N/A
Market Cap
$212.36M
N/A
Market Cap/Employee
$426.43K
N/A
Employees
498
N/A
Net Income
-$15.88M
-93.9%
EBITDA
-$15.04M
-103.8%
Quarterly Fundamentals
Total Cash
$217.88M
-5.0%
Total Debt
$10.83M
-10.1%
Accounts Receivable
$22.44M
-27.5%
Inventory
$34.87M
+47.9%
Long Term Debt
$9.32M
-15.2%
Short Term Debt
$1.50M
+42.6%
Return on Assets
-15.34%
N/A
Return on Invested Capital
-20.01%
N/A
Free Cash Flow
-$11.65M
-23.8%
Operating Cash Flow
-$10.89M
-23.3%